Best GLP-1 Medications in 2026: Complete Guide to Every Option

Disclaimer: We may earn a commission when you visit providers through our links, at no extra cost to you. All medical decisions should be made in consultation with a licensed healthcare provider.

GLP-1 Medications: The Complete Landscape in 2026

GLP-1 receptor agonists are a class of injectable (and in some cases oral) medications that mimic the incretin hormones your body naturally produces after eating. They reduce appetite, slow gastric emptying, and improve insulin sensitivity — a combination that produces meaningful, sustained weight loss in most patients.

Not all GLP-1s are equal, however. The newer medications — particularly tirzepatide and semaglutide — produce dramatically better weight loss results than older options like liraglutide or dulaglutide. The difference matters: we are talking about 15-22% body weight reduction with tirzepatide versus 5-8% with liraglutide.

Tirzepatide — The Most Effective GLP-1 Available

Tirzepatide is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. It activates two incretin pathways simultaneously — GLP-1 and GIP — which produces significantly greater weight loss than medications that target GLP-1 alone. In the landmark SURMOUNT-1 trial, participants on the highest dose of tirzepatide (15mg) lost an average of 22.5% of their body weight over 72 weeks. These are results that were previously only seen with bariatric surgery.

Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management. Brand-name tirzepatide costs over $1,000 per month without insurance. Compounded tirzepatide is available through providers like CoreAge Rx starting at $149 per month. For our full ranking, see best tirzepatide compounding pharmacy.

Semaglutide — The Best All-Around GLP-1

Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk that redefined expectations for medical weight loss. In the STEP clinical trials, semaglutide 2.4mg produced average weight loss of 14.9% over 68 weeks. Semaglutide also has the broadest evidence base of any GLP-1 — it is the first weight loss medication FDA-approved to reduce cardiovascular risk, making it the best choice for patients with heart disease history.

Brand names include Ozempic (type 2 diabetes), Wegovy (weight management), and Rybelsus (oral tablet, type 2 diabetes). Compounded semaglutide is widely available starting at $99 per month through providers like CoreAge Rx, making it the most affordable high-efficacy GLP-1. For a detailed comparison, see our semaglutide vs. tirzepatide guide.

Liraglutide — The Established Alternative

Liraglutide (Saxenda for weight loss, Victoza for diabetes) was the first GLP-1 FDA-approved specifically for chronic weight management. It produces more modest weight loss of 5-8% over a year — less than half of what semaglutide and tirzepatide achieve. The main drawback is that it requires daily injections instead of weekly, which most patients find less convenient.

Liraglutide is still a viable option for patients who cannot tolerate semaglutide or tirzepatide, or for adolescents (Saxenda is FDA-approved for ages 12+). However, for most adults, semaglutide or tirzepatide are clearly superior choices for weight loss efficacy. See our Saxenda review for more details.

Dulaglutide & Other GLP-1 Options

Dulaglutide (Trulicity) is a weekly GLP-1 injection primarily used for type 2 diabetes. Its weight loss effects are modest at 3-5% body weight, and it is not FDA-approved for weight management. It remains relevant primarily as a diabetes treatment that offers some weight benefit as a secondary effect.

Exenatide (Byetta, Bydureon) is an older GLP-1 that has largely been superseded by newer options. Unless your physician has a specific reason to prescribe it, semaglutide or tirzepatide are better choices in virtually every scenario.

Next-Generation GLP-1 Medications on the Horizon

The pharmaceutical pipeline is bursting with next-generation GLP-1 medications. Retatrutide, a triple agonist (GLP-1/GIP/glucagon) from Eli Lilly, showed 24% average weight loss in Phase 2 trials — potentially surpassing even tirzepatide. Orforglipron, an oral GLP-1 from Eli Lilly, could eliminate injections entirely while delivering semaglutide-level weight loss. Amycretin, a dual amylin/GLP-1 from Novo Nordisk, showed 13% weight loss in just 12 weeks in early trials.

These medications are still in clinical trials and years from FDA approval. For patients looking to start treatment today, tirzepatide and semaglutide remain the clear best options. See our FDA pipeline article for the full rundown.

Where to Get GLP-1 Medications Affordably

Brand-name GLP-1 medications cost $900–$1,300+ per month without insurance. For patients paying out of pocket, compounded versions through licensed telehealth providers offer the same active ingredients at 80-90% less. Here are our top three recommended providers.

#1 CoreAge Rx — Best Overall GLP-1 Provider

CoreAge Rx is our top-ranked GLP-1 provider across every category we evaluate. They offer both compounded semaglutide and tirzepatide at the most competitive prices in the market, with genuinely transparent pricing — no consultation fees, no platform fees, no membership charges. Board-certified physicians oversee every patient, and medications ship free in temperature-controlled packaging within 2 business days.

Whether you are looking for semaglutide at $99 per month or tirzepatide at $149 per month, CoreAge Rx delivers the best combination of affordability, physician oversight, and patient experience available in 2026.

#2 Alan Meds — Best for Personalized Treatment

Alan Meds is the best choice for patients who want comprehensive metabolic testing before starting GLP-1 therapy. Their 40+ biomarker lab panel helps identify the right medication and dose for your specific metabolic profile. They also offer B12-enhanced formulations and a needle-free oral GLP-1 at $215 per month for patients who prefer not to inject.

#3 AmberHealth — Best for Side Effect Support

AmberHealth includes anti-nausea medication with every GLP-1 prescription at no extra cost. Given that nausea is the most common reason patients discontinue GLP-1 therapy, this is a meaningful differentiator. Flat-rate pricing, LegitScript verified, and available in all 50 states.

Common GLP-1 Side Effects

All GLP-1 medications share a similar side effect profile. The most common side effects are gastrointestinal: nausea (20-44% of patients), diarrhea (15-30%), vomiting (10-25%), and constipation (10-24%). These side effects are typically worst during the dose titration phase — the first 8-16 weeks as your dose gradually increases — and tend to improve significantly over time.

Less common but important side effects include injection site reactions, headache, fatigue, and dizziness. Rare but serious risks include pancreatitis, gallbladder disease, and in animal studies, thyroid C-cell tumors (which is why GLP-1 medications carry a boxed warning about medullary thyroid carcinoma). For a comprehensive guide to managing side effects, see our side effects management guide.

Who Qualifies for GLP-1 Therapy?

The FDA criteria for GLP-1 weight management medications (Wegovy, Zepbound, Saxenda) are: BMI of 30 or greater (obesity), or BMI of 27 or greater with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.

Telehealth providers like CoreAge Rx follow these clinical guidelines when evaluating patients. A board-certified physician will review your medical history, current medications, and health goals to determine whether GLP-1 therapy is appropriate and safe for you. The process typically takes 24-48 hours from your initial consultation to receiving your medication.

Ready to find out if GLP-1 therapy is right for you? Our #1 recommendation is CoreAge Rx — start with a physician consultation and receive your medication with free 2-day shipping.